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 
Abstract— The state-of-the-art in monolith with proteins as 
chiral selectors for enantiomer separations is comprehensively 
reviewed, focused not only on those few literature specific to 
monoliths with proteins as chiral selectors, but also on the papers 
related to it.  Proteins or glycoproteins , through different ways, 
combined on monolithic columns comprising in situ organic 
polymer monoliths, silica monoliths or molecularly imprinted 
polymer monoliths are discussed herein. Thus, we can conclude 
monolithic columns with proteins as chiral selectors present a 
considerable promising future for enantiomer separations.  
 
Index Terms—monoliths, proteins, chiral selectors, 
separation 
 
I.  INTRODUCTION 
A lot of chemical compounds used in pharmaceutical 
formulations feature one or more chiral centers, responsible 
for optical activity, can strongly impact their 
pharmacological and pharmacokinetic properties. Therefore, 
development of new approaches for the separation of chiral 
compounds is a source of global research efforts and 
innovative incentives.  
The broad applicability of proteins as chiral selectors is 
evident in the large number of racemates separated so far, and 
is further expressed by simple adsorption or immobilization 
to the stationary phase for inducing a reversible change of the 
selector conformation, thus obtaining different 
enantioselective properties of the same protein. Because of 
their chiral nature and the variety of functional groups 
present at their surface, proteins can interact with chiral 
entities by forming not only relatively weak and non-specific 
bonds, but also stronger and more specific interactions 
[1],[2], which will be discussed specifically. 
In the past decade, monolithic separation media [3] have 
become popular and different types of monolithic materials, 
that is polymer monoliths, silica monolith, and molecularly 
imprinted polymer monoliths, have been developed, which 
will be elaborated later in the field of enantio-separation 
using proteins as chiral selectors. 
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II.  PROTEIN SELECTORS 
A.  General View 
A protein and glycoprotein, both of which are chiral,  have 
the possibility to discriminate a chiral molecule. However, 
only a limited number of proteins have been investigated as 
chiral selectors, including albumins and glycoproteins. The 
most extensively investigated protein ligands in chiral 
monoliths are bovine serum albumin (BSA), human serum 
albumin (HSA), and α-acid glycoprotein (AGP). 
Due to the structural complexity of these macromolecular 
protein selectors, their chiral recognition mechanisms at the 
molecular level remained unknown for a long time. However, 
with the advent of modern techniques, like protein NMR [4], 
X-ray crystallography [5] and docking studies [6], the 
mysterious mechanisms for chiral recognition are likely to be 
unveiled. The binding modes have become known for a 
number of protein–guest complexes[7]. 
B.  α-Acid Glycoprotein 
α-acid glycoprotein is one of glycoproteins used in chiral 
monolith. AGP is the major plasma protein responsible for 
the protein binding of cationic drugs because AGP has a 
lower isoelectric point (pI ) value than BSA and HSA.  
Hage and co-workers[8],[9] bound AGP via its 
carbohydrate chains after periodate oxidation to 
hydrazide-activated supports. Silica particles, silica 
monoliths and polymer monoliths based on glycidyl 
methacrylate (GMA) and ethylene glycol dimethacrylate 
(EDMA) were used as the support. The surface coverage of 
AGP in the silica monolith is 18% higher than that obtained 
with silica particles and 61% higher than that with a 
GMA/EDMA monolith. The higher surface area of the silica 
monolith gives materials that contain 1.5–3.6 times more 
immobilized protein per unit volume when compared. 
Besides the high heterogeneity of its glycans, the protein 
part of AGP has also shown polymorphism. The variants are 
encoded by two different genes: the F1-S variants are 
encoded by the alleles of the same gene, while the A variant 
is encoded by a different gene [10]. There is a difference of at 
least 22 amino acid residues between the F1-S (ORM 1) and 
A (ORM 2)variants, while F1 and S forms differ only in a few 
residues. Selective binding of coumarin enantiomers to 
human AGP genetic variants is investigated. All investigated 
compounds bound stronger to ORM 1 than to ORM 2 [11]. 
ORM 1 and human native AGP prefer the binding of 
(S)-enantiomers of warfarin and acenocoumarol, while no 
enantioselectivity is observed in phenprocoumon binding. 
Furthermore, a new homology model of AGP is built; the 
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models of ORM 1 and ORM 2 suggest that the binding 
cavity, including Trp122, for ORM 1 is the same with that for 
ORM 2. That difference in binding to AGP genetic variants 
can be caused by steric factors: ORM 2 form a smaller, more 
hydrophobic cavity as compared to ORM 1. Dockings to 
ORM 1 result in a much lower intermolecular energy than 
dockings to ORM 2, suggesting that although binding to both 
variants is possible, ORM 1 binding is more favorable. 
Energy differences between (R)- and (S)-enantiomers are not 
signiﬁcant and show a slight preference for (S)-enantiomers 
in the case of both ORM 1 and ORM 2[11]. 
Ligand-binding properties of AGP are also investigated by 
circular dichroism(CD) methods[12]. The induced CD 
spectra of drug–AGP complexes were observed with several 
class of drugs. Results of additional CD experiments 
performed by using recombinant AGP mutants show no 
changes in the ligand binding ability of Trp122Ala in sharp 
contrast with the Trp25Ala which is unable to induce 
extrinsic CD signal with either ligand. These ﬁndings suggest 
that, via π–π stacking mechanism, Trp25 is essentially 
involved in the AGP binding of drugs studied[12].  
C.  Human Serum Albumin and Bovine Serum Albumin  
Human serum albumin(HSA) has been thoroughly 
investigated owe to its important role as drug transporting 
plasma protein, which is also proved to be effective for the 
separation of enantiomers [13]. Enantioselective 
determination of bupivacaine, oxprenolol, propranolol in 
pharmaceuticals through HSA have been reported [14]. One 
of the main advanages of using HSA is the low cost per 
analysis (0.006 D /run), since HSA solution is not 
electrolyzed and can be reused for several runs[15].  
 Of several complexes of HSA with drugs or toxins, X-ray 
crystal structures have been discovered and are available via 
the Brookhaven protein data bank [16]，which can be seen 
of existing two primary binding sites for drugs and a number 
of secondary ones where drugs can bind with varying 
speciﬁcity. Of particular interest from a viewpoint of chiral 
recognition are X-ray crystal structures reported for warfarin 
because both of the diastereomeric complexes are available 
[17].Warfarin binds to the subdomain IIA and as can be seen, 
both R-and S-enantiomers bind in the pocket in almost 
identical conformations and geometric arrangement. 
Coumarin and benzylmoieties of the R- and S-forms are 
nearly perfectly superimposable in overlaid complexes. The 
main difference in the drug is related to conformations in the 
acetonyl group and to H-bond interactions that are formed 
between Arg222 residue and the carbonyl of the coumarin 
ring (in R-complex) and of the acetonide (in S-complex) 
[18]. The enantiomers bind in essentially the same way to 
HSA is consistent with the observation that they have similar 
binding affinities for the protein which is thus characterized 
for a low degree of enantioselectivity for warfarin 
enantiomers. 
Afﬁnity capillary electrochromatography (CEC) with 
zonal elution method is used to probe the competitive 
interactions of enantiomers with bovine serum albumin 
(BSA)[19]. The binding sites of solutes on the BSA molecule 
are determined by the changes in the retention factors of the 
solutes resulted from the addition of competitive agent. By 
using D- or L-tryptophan as competitive agents and D-, 
L-tryptophan and benzoin enantiomers as injected analytes 
show that BSA molecule has a primary site to strongly bind 
L-tryptophan, but D-tryptophan dose not bind at this site; 
D-and L-tryptophan share a weak binding site on the BSA 
molecule. Benzoin enantiomers do not share any binding 
sites with either D-or L-tryptophan. Non-chiral compounds 
of trichloroacetic acid and n-hexanoic acid are applied as the 
competitive agents to study the binding of warfarin 
enantiomers to BSA, and it is observed that trichloroacetic 
acid and n-hexanoic acid have a same binding site for 
warfarin enantiomers binding to BSA molecule. 
III.  MONOLITHS 
A.  General Remarks  
Traditionally, the preparation of column with protein as 
chiral selector is either through direct coating or through 
particles carrying chiral selector. Direct covalent binding of 
BSA to the internal surface of a capillary for enantiomer 
separation belongs to the former category[20]. These 
capillaries are operable up to one year when stored properly 
at 48℃[20], but this form of easy desorption property is well 
known. Thus, using silica particles carrying a chiral selector 
becomes another option .The packing bed is retained by frits 
at both ends of the capillary, which is complicated and shows 
limited reproducibility. The problem here is that frits are a 
source of air bubbles and they break easily.  
To circumvent these problems, columns consisting of a 
block of a porous solid, called monolith or rod, prepared on a 
silica base either by a sol-gel process using polycondensation 
of alkoxysilanes or by polymerization of organic monomers, 
is developed. The essential advantages of monolithic 
columns come from the possibility to optimize proportions of 
monomers and cross-linkers so as to control the average size 
of the throughput channels and the porons. More and more 
analysts have sensed these advantages, and have achieved a 
lot of groundbreaking  findings in this area, especially the 
monolithic applications in separation science . Therefore, 
there is no wonder that reviews on the preparation of 
monoliths with chiral surface flourish in recent 
years[21]-[25]. However, as far as we know, not any review 
is exclusively focused on the monoliths with protein as chiral 
selectors. In this section, the preparation of monoliths with 
protein as chiral selectors would be introduced in detail, and 
we hope this article can illuminate those who are interested in 
preparing “protein” monoliths.  
B.  Polymer-based Monoliths 
Early developments of stereoselective capillary 
electrophoresis with gel-ﬁlled columns or completely 
homogeneous separation media with BSA physically or 
chemically incorporated in slightly crosslinked neutral gel 
matrixes may be regarded as pioneer works [26]. The 
challenge in the course of development of enantioselective 
organic polymer-type monolithic capillary columns is to get a 
grasp on the complex interrelations between chiral 
recognition, EOF control, non-speciﬁc adsorption, retention 
balance, rigidity and permeability without negative mutual 
effects [27]. This may be the reason why so few recent 
published articles about fabricating polymer-based monolith 
with protein as chiral selector could be found, even though 
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more preparation studies of polymer-based monoliths are 
discussed and developed , including different monomers, 
porogens, and ways of polymerization[28]. 
A new kind of immobilized HSA column  based on poly 
(GMA-EDMA) as the support of high-performance afﬁnity 
chromatography[29] is  one of them. Using the epoxide 
functional groups presented in GMA, the HSA 
immobilization procedure was performed by two different 
means: Epoxy means and EDA(Ethylene Diamine) means. 
The monoliths are successfully adopted for the chiral 
separation of D,L-amino acids(AAs) and are shown to be 
applicable to the quantitative analysis of D-tryptophan and 
are used for the analysis of urine samples[29]. Despite no 
signiﬁcant difference between two immobilization means 
have been observed either in the separation results or stability 
of the prepared protein columns, the process of EDA means 
was quite complicated and time-consuming. Moreover, 
another disadvantage of this immobilization means is a 
potential for production of undesirable by-products, like 
homoconjugates and various polymers [30]. Therefore, the 
simpler epoxy mean is more frequently applied. 
C.  Silica-based Monoliths 
Macroporous polymers based on GMA and EDMA have 
been employed in many studies to create affinity monoliths. 
However, the relative large number of publications in which 
affinity ligands have been used with silica monoliths is 
surprising since these supports offer several potential 
advantages. One of these possible advantages is the high 
surface area of these materials, which would be expected to 
allow for a high level of immobilized protein attachment. 
Another expected advantage of silica monoliths is their 
ability to use the same immobilization methods with these 
supports that are employed when attaching different affinity 
ligands to silica particles [31]. 
Enantioselective silica monoliths are commonly obtained 
by post-functionalization with chiral selector sites. 
Therefore, not many attempts have been made to prepare 
chiral silica-based monoliths in situ by single-step concepts. 
Protein-encapsulation into a sol–gel matrix during its 
formation constitutes this in situ preparation 
approach[32]-[34]. BSA or ovomucoid(OVM) was 
add-mixed to a fully or partially hydrolyzed silica precursor, 
injected into the capillary and the protein finally trapped in 
the silica network. In the initial study, successful separations 
of Trp could only be obtained with a gel which was made 
from TMOS and MTMS, but not with gels made from TMOS 
alone. Later, Kato et al. [34] developed a novel sol–gel 
method, encapsulating BSA or OVM into TMOS-based silica 
matrix in a single step within a capillary. Because no further 
thermal treatment was performed, a monolith composed of a 
TMOS-based hydrogel was formed without shrinking. 
Column fabrication also involved an aging step of the gel for 
about three days after which the proteins were completely 
encapsulated in the gel network.  Enantiomeric separation of 
tryptophan and benzoin was achieved on a 
BSA-encapsulated monolith and the enantiomers of 
eperisone, chlorpheniramine and benzoin were resolved on 
an OVM-encapsulated monolith. Under optimized 
conditions, theoretical plate number for the first eluted 
enantiomer of benzoin reached 72,000 plates per meter. 
While the run-to-run repeatability was quite satisfactory, 
the lifetime of the monolithic capillary was a problem due to 
the loss or denaturing of the proteins. In a further paper of the 
same group [33], BSA-encapsulated monoliths were 
characterized by their attenuated total 
reﬂectance-FT-IR(ATR-FT-IR)[32] and a similar 
methodology was employed by using the natural polymers 
gelatine or chitosan as copolymers during the sol–gel 
process, a more stable BSA-encapsulated silica monolith 
with somewhat higher enantioselectivity generated [35]. 
The preparation of a silica monolith for the immobilization 
of HSA was also examined, using the epoxy immobilization 
method for attaching proteins to silica monoliths [36]. 
However, it is known that the epoxy method tends to give 
lower activities and lower protein coverage for HSA than 
other amine-based coupling methods [37]. Work in Rangan's 
study[38]  used the Schiff base, an immobilization method 
which gives better results for HSA when used with other 
support materials [39]. NaBH4 phosphate solution (pH 8.2) 
is used to reduce double bond C=N to single bond C–N, 
which may pose great danger to researchers’ life. A mild 
reducing agent(sodium cyanoborohydride) was also present 
during this reaction to reduce the Schiff base to a more stable 
secondary amine linkage[38]， which is illustrated in Figure 
1. 
 
Fig. 1. Reactions for the preparation of an HSA silica monolith. 
Abbreviation: HSA, human serum albumin. 
 
  Through another way, HSA is immobilized via its 
sulfhydryl groups [40]. Amino-silica is activated by 
succinimidyl 
4-(N-maleimidomethyl)cyclohexane-1-carboxylate(SMCC) 
followed by reaction with a sulfhydryl group of the protein. 
Similarly, amino-silica is activated by succinimidyl 
iodoacetate (SIC) for reaction with a sulfhydryl group. 
Maleimide-activated silica(the SMCC method) or 
iodoacetyl-activated silica (the SIA method) is used for these 
methods. It is found that the SMCC and SIA methods gave 
HSA-based monolith with comparable or improved activity 
and stability, compared to those made by the Schiff base 
method. 
Often, the preparation of a silica monolith for the AGP 
selector has been immobilized onto epoxy-activated supports 
[41],[42] or through the hydrazide immobilization method, a 
technique that has been shown to give site-selective coupling 
for glycoproteins like AGP, as demonstrated in previous 
work with silica particles [43],[44]. Prior to immobilization, 
the carbohydrate residues on AGP were oxidized under mild 
conditions to generate aldehyde groups, approximately, ﬁve 
reactive aldehyde groups per AGP molecule[45]. 
Apart from encapsulation or immobilization ways, the way 
of direct adsorption, although not as common as in the 
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preparation of monolith, is also evolving. Liu et al. [46] 
reported fabrication of silica-based monolithic capillaries 
with physically adsorbed avidin as chiral selector. 
Enantiomeric separations of amino acid derivatives, several 
organic acids, menadione sodium bisulﬁte, warfarin and 
N-methylpseudoephedrine were achieved in both 
nano-HPLC and CEC mode. Theoretical plate numbers of 
122,000 per meter for nano-HPLC and 242,000 per meter for 
CEC were observed.   
There have been several attempts to prepare particle-based 
monolith, using silica particles bearing a chiral selector 
without the need for end frit preparation. In all cases, the 
immobilization of the packing material inside the capillary 
requires one additional preparation step. Such capillaries 
have been obtained, for example, by packing silica material 
into a tube followed by subsequent sintering of the whole 
packing material [47], by passing a sol solution of silicate 
[48] or alkoxysilanes through a pre-packed column [49], or 
by pumping a methacrylate solution through the column prior 
to polymerization[50]. Another attempt to prepare 
particle-based capillaries without end frits was published by 
Kato et al [51]. They prepared particle-loaded phases using a 
sol-gel technique by suspending silica particles containing a 
chemically bonded chiral selector in a solution of tetraethyl 
orthosilicate, which was forced into a piece of tubing. 
Prepared particle-loaded monoliths were characterized by 
means of electron microscopy. An almost homogeneous 
distribution of silica particles could be achieved by various 
optimizations of the polymerization mixture used. 
Interestingly, silica particles were only slightly crosslinked 
by the polymeric backbone, leaving the majority of the silica 
particle surface unaffected. As chiral separation takes place 
only at the surface of silica particles bearing the chiral 
selector, this should lead to good separation performance.  
D.  Molecularly Imprinted Polymer Monoliths 
Molecularly imprinted polymers (MIPs), another popular 
technique for enantioselective binding-sites creation, have a 
potential in the separation of chiral compounds, predicting 
not only the recognition ability but also the elution order 
[52]-[54]. Applications of MIP as separation media in LC, 
CE and CEC for chiral separation have been extensively 
investigated[55],[56]. The MIP monolith of CEC has the 
advantage of minimal chemical consumptions, especially the 
imprinted molecule.  
To date, the imprinting of small molecules has been 
well-established and considered almost routine. However, 
the imprinting of biomacromolecules, such as proteins and 
peptides, continues to be a signiﬁcant challenge due to 
difficulties with large molecular sizes, structural complexity, 
environmental sensitivity of the templates, and signiﬁcantly 
reduced non-covalent template monomer interactions in 
aqueous media [57]-[59]. Despite these difficulties, there is 
still a strong incentive to synthesis MIPs of 
biomacromolecules and quite a few attempts have been made 
with more or less success.  
For example, an approach using systematic optimization 
for the formation of an albumin MIP has been prepared by 
imprinting albumin using a copolymer comprising 
3-dimethylaminopropylmethacrylate and tetraethylene 
glycol dimethacrylate in a mole ratio of 1 to 8. Cytochrome c, 
lysozyme and myoglobin were used in competitive rebinding 
experiments to compete with the polymer's native template 
with all protein species present at 0.0004 g/mL. It has been 
investigated that 0.125 mole ratio of monomer to crosslinker, 
6.04 wt.% water content with respect to the mass of the 
monomer complex, 60h polymerization time at 38 °C, and 
with 0.47% albumin in the prepolymerization monomer 
complex can obtain the optimum condition[60].  
Three major challenges can be encountered for MIP taking 
proteins as template. First challenge is diffusional limitations 
in large molecular weight for molecularly imprinted 
polymers, which is attributed to the high crosslinking 
required to achieve recognition. Another problem is the 
difficulty of protein dissolution in the monomer solution and 
the low solubility of these structures in non-aqueous solvents. 
Most of the protein-imprinted polymers demonstrated to date 
show very low template rebinding, which forms the third 
challenge. Few exhibit rebinding capacity high enough for 
some applications such as bioseparation. Among these, 
Guo’s group[61]-[63]fabricated bovine hemoglobin 
(Hb)-imprinted polymers by the combined use of chitosan, 
presenting a high Hb rebinding capacity of above 20 mg/g 
wet gels, while the non-imprinted polymers(NIPs) bound 
very little Hb. However, Guo found that these high binding 
results are difficult to explain reasonably. Through X-ray 
diffraction and scanning electronic microscope 
investigations, a remarkable property changes of the NIPs 
after the washing process is confirmed. These ﬁndings[64] 
indicate that the non-speciﬁc adsorption resulting from the 
template removing process rather than the imprinted sites 
generated on the MIPs themselves may account for the high 
template rebinding capacity of the reported protein-imprinted 
polymers.  
The development of MIP monolithic column may 
overcome these disadvantages to a great extent. MIP 
monoliths have rapidly evolved in recent years [65]-[67],  
since Matsui et al. [68] employed an in situ polymerization 
technique to prepare MIP monolithic rods in 1993. 
Depending on the monolithic material, the MIP monolithic 
matrix can be divided into organic polymer-based and 
silica-based monolith. In comparison of a host of 
polymer-based MIP monoliths used for enatioseparation, 
only few publications [69] reported on the preparation of a 
silica-based MIP capillary monolithic column for 
enantioseparation of small molecules since the sol–gel 
process is difficult to control and often associated with the 
cracking and shrinking of silica skeleton during drying. To 
solve these difficulties, Wang et al. [70] have developed an 
attractive method for fabrication of a hybrid silica-based MIP 
capillary monolith based on room temperature ionic 
liquid-mediated, non-hydrolytic sol–gel process, with which 
chiral separation of naproxen has been achieved by capillary 
electrochromatography. Lina[71] further focused on the 
development of a novel hybrid silica-based MIP monolith 
technology and its first application in protein recognition. 
The macroporous silica-based monolithic skeleton was 
synthesized in a 4.6mm i.d. stainless steel column by a mild 
sol–gel process with methyltrimethoxysilane (MTMS) as a 
sole precursor, and BSA and lysozyme(Lyz) were 
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representatively selected for imprinted templates（Fig. 2）. 
Under the optimum conditions, the obtained hybrid 
silica-based MIP monolith showed higher binding affinity for 
template than its corresponding non-imprinted (NIP) 
monolith. The imprinted factor (IF) for BSA and Lyz reached 
9.07 and 6.52, respectively. Moreover, the hybrid 
silica-based MIP monolith displayed favorable binding 
characteristics for template over competitive protein. 
Compared with the imprinted silica beads and in situ organic 
polymer-based hydrogel MIP monolith, the hybrid silica MIP 
monolith exhibit better chromatographic performances[71]. 
 
Fig.2. Schematic representation of preparation procedures of hybrid 
silica-based MIP monolithic column. (1) Bare stainless steel column; (2) 
naked silica skeleton prepared by sol–gel process; (3) silanols on the surface 
of silica monolith; (4) vinylation on the surface of silica monolith; (5) 
formation of MIP coating on the surface of silica monolith;(6) removal of 
template protein. 
 
The combination of MIP with chiral separation through 
macromolecules, at early times, only came  from papers 
comparing the prepared MIP with commercially available 
chiral stationary phases. For example, the baseline separation 
of nilvadipine enantiomers thorough MIP was comapared 
with columns based on the protein (ovomucoid or α-acid 
glycoprotein) [72]. 
However, apart from applications of bioseparation and 
biosensors, no imprinting of protein has been applied for 
chiral separation. This may due to that macromolecular MIP 
is so difficult to fabricate and even if MIP was successfully 
prepared, the predetermined specificity would lose its halo. 
Another reason for not being reported in the field of 
enatiomer separation is probably that MIP with small 
molecules like mimic enatiomers have already met the 
demand of chiral analysis. Despite of above reasons, 
application of protein MIP for enatiomer separation still 
needs to be discussed and studied, for it can efficiently avoid 
requirement of highly-purified one enatiomer as temaplate 
and can provide more active sites for chiral separation.     
E.  Evaluation of monoliths 
After fabrication of monolith, often a crucial step need to 
be undertaken, that is the evaluation process through various 
parameters from different perspective. However, up to now, 
in contrast with traditional chromatographic columns, no 
strict or universal assessment system has been established. 
Paper between paper and column between column, even if 
the same type, would appear totally different types of 
measurements.  
Several methods have been proposed to compare the 
performance of monolithic and packed columns, through the 
Hans Poppe plots [73], through various kinetic plots [74], 
and through column impedance[75], and of a few other 
approaches. The column impedance is a performance index 
that relates the hold-up time of a column and its efficiency 
[75],to the mobile phase viscosity and the inlet pressure 
available. The initial success of these various methods owes 
much to the initial ignorance of the scientiﬁc community 
regarding the properties of monolithic columns and their 
advantages and inconvenient compared to those of packed 
columns. Their use has much contributed to clarify the 
situation.  
Pore size distribution of monolithic columns has always 
been one of the most challenging issues and often 
characterized by a bimodal pore size distribution[76], 
throughpores controlling the column permeability, and 
mesopore structure controlling the mass transfer kinetics and 
the column efficiency[77]. Porogenic distributions are often 
measured by Mercury Intrusion (MI), Scanning Electron 
Microscopy(SEM), and Nitrogen Adsorption method, which 
have turned a routine test[78]-[82].  
Protein content is of great importance in monoliths with 
protein as chiral selectors. Through  infrared spectroscopy of 
bare monolithic material and monolith with immobilized 
chiral selectors, their comparison and adsorption strength can 
evaluate whether the successful immobilization is achieved 
or not. Another method to estimate protein content is to add 
some indicator. For example, an estimate of the total protein 
content in the monolith is obtained by injecting a 0.1% (w/v) 
solution of copper sulfate onto the AGP columns. This 
method uses copper sulfate as a probe for the overall 
ion-exchange capability of the immobilized proteins [83]. 
Using carbamazepine, an analyte that has a single primary 
site on AGP, to make frontal analysis can also estimate the 
binding capacity and total amount of protein in the AGP 
silica monolith. 
IV.  CONCLUSIONS 
With the development of monolithic technique, more and 
more reviews about monoliths  have been published, 
stressing from different perspective of view. Chiral 
separation has always been of great interest to researchers, 
and application of monoliths for enatio-separation is fair and 
reasonable. Be that as it may, monolith with proteins as chiral 
selectors for enatiomer separation is rarely investigated. 
Therefore, a discussion is conducted based on the 
multidisciplinary fields(i.e. biomolecule, biomaterial, 
pharmacy and analytical chemistry). Proteins used as chiral 
selectors and different types of monolithic technologies have 
been introduced in detail. It is our purpose to inspire readers 
who devote their time to chiral separation or to monolithic 
applications, that monolithic columns with proteins as chiral 
selectors may present a promising and alternative approach 
for enantiomer separations. 
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